Submucosal hyper-echogenicity on intestinal ultrasound is associated with fat deposition and predicts treatment non-response in patients with ulcerative colitis - Top-Institutions - MDSpire

Submucosal hyper-echogenicity on intestinal ultrasound is associated with fat deposition and predicts treatment non-response in patients with ulcerative colitis

  • By

  • Maarten J Pruijt

  • E Andra Neefjes-Borst

  • Floris A E De Voogd

  • Marilyne M Lange

  • Christoph Teichert

  • Reimer J Janssen

  • Geert R D’Haens

  • Krisztina B Gecse

  • November 4, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Medical Imaging

  • #2

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Ultrasound Imaging

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Medical Imaging

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Ultrasound Diagnostics

Original Source(s)

Submucosal hyper-echogenicity on intestinal ultrasound is associated with fat deposition and predicts treatment non-response in patients with ulcerative colitis

  • by Maarten J Pruijt, E Andra Neefjes-Borst, Floris A E De Voogd, Marilyne M Lange, Christoph Teichert, Reimer J Janssen, Geert R D’Haens, Krisztina B Gecse

  • November 4, 2025

Related Content

Factors Linked to Moderate-to-Severe Ulcerative Colitis: Insights from a Retrospective Case-Control Analysis

The innovation trap: How pharma weaponizes a word to extend monopolies

Proton Pump Inhibitors and Cancer Risk

Investigators evaluate cancer risk tied to extended acid suppression therapy.